Objective:

To provide updated insights into the pathophysiology of ovarian aging and recent developments aimed at preserving or restoring ovarian function, highlighting the urgent need for effective strategies in reproductive medicine.

Approach:

Key Findings:

• Ovarian aging involves both quantitative and qualitative declines in the follicular pool and oocyte quality, as evidenced by multiple studies.
• Inflammatory and paracrine environments significantly influence ovarian reserve, supported by recent research.
• Mathematical models can enhance predictive accuracy for ART outcomes beyond chronological age, as demonstrated in the literature.
• Growth hormone may improve outcomes in patients with diminished ovarian reserve but requires careful application and further validation.
• Oxidative stress is a critical factor affecting reproductive capacity and embryo competence, as highlighted in several studies.

Interpretation:

The editorial emphasizes the multidisciplinary nature of ovarian aging research and the need for continued exploration of mechanisms and interventions.

Limitations:

• The complexity of cellular senescence pathways in ovarian injury complicates single-molecule targeting, as shown in recent findings.
• Clinical applications of growth hormone require stronger evidence regarding efficacy and safety, particularly in diverse patient populations.

Conclusion:

The editorial highlights the urgent need for strategies to maintain ovarian reserve in the face of aging and related reproductive challenges.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.